Eric A. Weaver

Family Medicine
2720 Plaza Dr Ste 1300
Wausau, WI 54401

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

Dual-route H5N1 vaccination induces systemic and mucosal immunity in murine and bovine models.

Dual-route H5N1 vaccination induces systemic and mucosal immunity in murine and bovine models.

Journal: NPJ vaccines
Published: December 17, 2025

Dual-Route H5N1 Vaccination Induces Systemic and Mucosal Immunity in Murine and Bovine Models.

Dual-Route H5N1 Vaccination Induces Systemic and Mucosal Immunity in Murine and Bovine Models.

Journal: bioRxiv : the preprint server for biology
Published: September 26, 2025

Systemic and Mucosal Immune Responses Induced by Adenoviral-Vectored Consensus H5 Influenza A Vaccines in Mice and Swine.

Systemic and Mucosal Immune Responses Induced by Adenoviral-Vectored Consensus H5 Influenza A Vaccines in Mice and Swine.

Journal: Vaccines
Published: August 05, 2025

Synthetic Neuraminidase Vaccine Induces Cross-Species and Multi-Subtype Protection.

Synthetic Neuraminidase Vaccine Induces Cross-Species and Multi-Subtype Protection.

Journal: Vaccines
Published: February 14, 2025

Impact of residential hot water heater type and water stagnation on drinking water quality within a full-scale premise plumbing system.

Impact of residential hot water heater type and water stagnation on drinking water quality within a full-scale premise plumbing system.

Journal: Environmental advances
Published: February 10, 2025

Adenoviral-Vectored Multivalent Vaccine Provides Durable Protection Against Influenza B Viruses from Victoria-like and Yamagata-like Lineages.

Adenoviral-Vectored Multivalent Vaccine Provides Durable Protection Against Influenza B Viruses from Victoria-like and Yamagata-like Lineages.

Journal: International journal of molecular sciences
Published: January 17, 2025

Epitope-optimized vaccine elicits enduring immunity against swine influenza A virus.

Epitope-optimized vaccine elicits enduring immunity against swine influenza A virus.

Journal: Nature communications
Published: September 12, 2024

Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza viruses.

Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza viruses.

Journal: mSphere
Published: August 01, 2024

Influenza B Virus Vaccine Innovation through Computational Design.

Influenza B Virus Vaccine Innovation through Computational Design.

Journal: Pathogens (Basel, Switzerland)
Published: July 30, 2024

Immunity and Protective Efficacy of a Plant-Based Tobacco Mosaic Virus-like Nanoparticle Vaccine against Influenza a Virus in Mice.

Immunity and Protective Efficacy of a Plant-Based Tobacco Mosaic Virus-like Nanoparticle Vaccine against Influenza a Virus in Mice.

Journal: Vaccines
Published: July 29, 2024

Immunogenicity and Protective Efficacy of Dose-Sparing Epigraph Vaccine against H3 Swine Influenza A Virus.

Immunogenicity and Protective Efficacy of Dose-Sparing Epigraph Vaccine against H3 Swine Influenza A Virus.

Journal: Vaccines
Published: July 26, 2024

Multivalent Epigraph Hemagglutinin Vaccine Protects against Influenza B Virus in Mice.

Multivalent Epigraph Hemagglutinin Vaccine Protects against Influenza B Virus in Mice.

Journal: Pathogens (Basel, Switzerland)
Published: December 23, 2023
Showing 1-12 of 60

Last Updated: 09/26/2026